NORADRENALINE (TARTRATE) AGUETTANT

Medicinal product

(Invented) name

NORADRENALINE (TARTRATE) AGUETTANT

Active substance (s)

Norepinefrino tartratas

Strength

2 mg/ml

Pharmaceutical form

koncentratas infuziniam tirpalui

Route (s) of administration

leisti į veną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C01CA03, Norepinephrine

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2025-06-04

Date of renewal

Documents

2628_NORADRENALINE (TARTRATE) AGUETTANT konc_inf_tirp_PZ_2025-06-04.docx

2628_NORADRENALINE (TARTRATE) AGUETTANT konc_inf_tirp_PL_2025-06-04.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

1 ml koncentrato yra:	1 ml
Norepinefrino tartratas	2 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
117707	103811	1103811	ampulė	4 ml N10		Receptinis	LT/L/25/2628/001	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2025-06-04	Registruotas